Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2

被引:47
|
作者
Ladurner, AG [1 ]
Itzhaki, LS [1 ]
Gay, GD [1 ]
Fersht, AR [1 ]
机构
[1] MRC,CAMBRIDGE CTR PROT ENGN,CAMBRIDGE CB2 2QH,ENGLAND
关键词
protein folding; nascent polypeptide; chymotrypsin inhibitor 2; protein engineering;
D O I
10.1006/jmbi.1997.1303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chymotrypsin inhibitor 2 (CI2) folds kinetically as a single domain protein. It has been shown that elements of native secondary structure do not significantly form in fragments as the 64 residue protein is progress ively increased in length from its N terminus, until at least 60 residues are present. Here, we analyse peptides of increasing length from the C terminus and find that native-like structure is not present even in the largest, fragment (7-64). We have examined sets of peptides of the form (1-x) and ((x + 1)-64) to detect complementation. The only pair that readily complements and gives native-like structure is (1-40) and (41-64), where cleavage occurs in the protease-binding loop of CI2. But, all the pairs of peptides (1 - x) + (41-64) complement for x > 40, as do all pairs of (1-40) + (x-64), where x < 40. The resultant complexes appear to be equivalent to (1-40).(41-64) with the overlapping sequence being unstructured. Thus, the folding of CI2 is extremely co-operative, and interactions have to be made between subdomains (1-40) and (41-64). This is consistent with the mechanism proposed for the folding pathway of intact CI2 in which a diffuse nucleus is formed in the transition state between the a-helix in the N-terminal region of the protein and conserved hydrophobic contacts in the C-terminal region of the polypeptide. It is with these protein design features that CI2 can be an effective protease inhibitor. (C) 1997 Academic Press Limited.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [21] Fusion protein of single-chain variable domain fragments for treatment of myasthenia gravis
    Li, Fangfang
    Meng, Fanping
    Jin, Quanxin
    Sun, Changyuan
    Li, Yingxin
    Li, Honghua
    Jin, Songzhu
    NEURAL REGENERATION RESEARCH, 2014, 9 (08) : 851 - 856
  • [22] Selection of Stabilized Variants of Chymotrypsin Inhibitor 2
    Teilum, Kaare
    Nielsen, Louise
    Gavrilov, Yulian
    Olsen, Johan
    Roche, Jennifer
    Nielsen, Alex
    Lindorff-Larsen, Kresten
    FASEB JOURNAL, 2020, 34
  • [23] Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III
    Zu, Xiangyang
    Liu, Yang
    Wang, Shaobo
    Jin, Rui
    Zhou, Zheng
    Liu, Haibin
    Gong, Rui
    Xiao, Gengfu
    Wang, Wei
    ANTIVIRAL RESEARCH, 2014, 104 : 7 - 14
  • [24] Electrostatic interactions in the reconstitution of an SH2 domain from constituent peptide fragments
    Ojennus, DD
    Lehto, SE
    Wuttke, DS
    PROTEIN SCIENCE, 2003, 12 (01) : 44 - 55
  • [25] Strain in the folding nucleus of chymotrypsin inhibitor 2
    Ladurner, AG
    Itzhaki, LS
    Fersht, AR
    FOLDING & DESIGN, 1997, 2 (06): : 363 - 368
  • [26] Surface-Templated Fibril Growth of Peptide Fragments from the Shaft Domain of the Adenovirus Fibre Protein
    Sedman, Victoria L.
    Kasotakis, Emmanouil
    Chen, Xinyong
    Allen, Stephanie
    Roberts, Clive J.
    Mitraki, Anna
    Tendler, Saul J. B.
    PROTEIN AND PEPTIDE LETTERS, 2011, 18 (03): : 268 - 274
  • [27] ISOLATION OF PROTEIN CHYMOTRYPSIN INHIBITOR FROM HONEY LOCUST SEEDS
    MOSOLOV, VV
    VALUEVA, TA
    KOLOSOVA, GV
    BIOCHEMISTRY-MOSCOW, 1982, 47 (12) : 1710 - 1715
  • [28] The Fanconi anemia complementation group A protein contains a peroxidase domain
    Mian, IS
    Moser, MJ
    MOLECULAR GENETICS AND METABOLISM, 1998, 63 (03) : 230 - 234
  • [29] Protein-protein interactions monitored in mammalian cells via complementation of β-lactamase enzyme fragments
    Wehrman, T
    Kleaveland, B
    Her, JH
    Balint, RF
    Blau, HM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) : 3469 - 3474
  • [30] Selection of a cyclic nonapeptide inhibitor to α-chymotrypsin using a phage display peptide library
    Krook, M
    Lindbladh, C
    Eriksen, JA
    Mosbach, K
    MOLECULAR DIVERSITY, 1998, 3 (03) : 149 - 159